STELIOS PAPADOPOULOS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STELIOS PAPADOPOULOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STELIOS PAPADOPOULOS. STELIOS PAPADOPOULOS is Director in BIOGEN INC. ($IDPH) and Director in EXELIXIS, INC. ($EXEL) and Director in BG Medicine, Inc. ($BGMD) and Director in Regulus Therapeutics Inc. ($RGLS) and Director in Eucrates Biomedical Acquisition Corp. ($EUCR).
Latest Insider Trading Transactions of STELIOS PAPADOPOULOS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BGMD, IDPH, EUCRW, EXEL, RGLS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 3.13 | 40,000 | 125,200 | 0 | |
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 6.30 | 40,000 | 252,000 | 0 | |
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.01 | 5,473 | 136,880 | 1,288,127 | 1.3 M to 1.3 M (-0.42 %) |
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 3.38 | 40,000 | 135,200 | 1,293,600 | 1.3 M to 1.3 M (+3.19 %) |
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.00 | 5,075 | 126,875 | 1,253,600 | 1.3 M to 1.3 M (-0.40 %) |
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 3.13 | 40,000 | 125,200 | 1,258,675 | 1.2 M to 1.3 M (+3.28 %) |
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 24.95 | 10,222 | 255,039 | 1,218,675 | 1.2 M to 1.2 M (-0.83 %) |
May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 6.30 | 40,000 | 252,000 | 1,228,897 | 1.2 M to 1.2 M (+3.36 %) |
Dec 07 2020 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.75 | 595,146 | 444,217 | 595,146 | |
Dec 07 2020 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Grant | A | 0.63 | 793,528 | 500,002 | 1,986,729 | 1.2 M to 2 M (+66.50 %) |
Nov 27 2020 | EUCR | Eucrates Biomedica ... | PAPADOPOULOS STELIOS | Director | Sell | J | 0.00 | 255,094 | 0 | 2,619,906 | 2.9 M to 2.6 M (-8.87 %) |
Jun 19 2020 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.88 | 23,250 | 20,460 | 23,250 | |
Jun 05 2020 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,470 | 0 | 6,565 | 5.1 K to 6.6 K (+28.85 %) |
May 22 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 15,538 | 0 | 1,188,897 | 1.2 M to 1.2 M (+1.32 %) |
May 22 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 15,538 | 0 | 1,188,897 | 1.2 M to 1.2 M (+1.32 %) |
May 15 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 5.82 | 120,791 | 703,004 | 0 | |
May 15 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 5.82 | 120,791 | 703,004 | 1,173,359 | 1.1 M to 1.2 M (+11.48 %) |
May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 5.92 | 15,000 | 88,800 | 0 | |
May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 4.58 | 30,000 | 137,400 | 0 | |
May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.84 | 45,000 | 1,162,800 | 1,052,568 | 1.1 M to 1.1 M (-4.10 %) |
May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 5.92 | 15,000 | 88,800 | 1,097,568 | 1.1 M to 1.1 M (+1.39 %) |
May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 4.58 | 30,000 | 137,400 | 1,082,568 | 1.1 M to 1.1 M (+2.85 %) |
Feb 04 2020 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | C | 0.00 | 84,632 | 0 | 0 | |
Feb 04 2020 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | C | 0.00 | 846,320 | 0 | 2,039,521 | 1.2 M to 2 M (+70.93 %) |
Dec 26 2019 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.67 | 846,320 | 563,649 | 846,320 | |
Dec 26 2019 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.00 | 84,632 | 0 | 84,632 | |
Oct 15 2019 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.64 | 46,500 | 29,760 | 46,500 | |
Oct 15 2019 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.64 | 46,500 | 29,760 | 46,500 | |
Jun 20 2019 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,905 | 0 | 5,095 | 3.2 K to 5.1 K (+59.72 %) |
May 24 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 19.77 | 20,634 | 407,934 | 20,634 | |
May 24 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 10,317 | 0 | 1,052,568 | 1 M to 1.1 M (+0.99 %) |
May 08 2019 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | P | 1.08 | 370,370 | 400,000 | 370,370 | |
May 08 2019 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.08 | 370,370 | 400,000 | 1,189,872 | 819.5 K to 1.2 M (+45.19 %) |
Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 4.57 | 15,000 | 68,550 | 0 | |
Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 4.16 | 11,250 | 46,800 | 0 | |
Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 21.25 | 26,250 | 557,813 | 1,042,251 | 1.1 M to 1 M (-2.46 %) |
Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 4.57 | 15,000 | 68,550 | 1,068,501 | 1.1 M to 1.1 M (+1.42 %) |
Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 4.16 | 11,250 | 46,800 | 1,053,501 | 1 M to 1.1 M (+1.08 %) |
Jan 02 2019 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.09 | 50,000 | 54,570 | 835,073 | 785.1 K to 835.1 K (+6.37 %) |
Dec 28 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.04 | 26,401 | 27,460 | 785,073 | 758.7 K to 785.1 K (+3.48 %) |
Dec 28 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 0.95 | 90,000 | 85,878 | 758,672 | 668.7 K to 758.7 K (+13.46 %) |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | D | 8.76 | 4,583 | 40,147 | 0 | |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | D | 8.52 | 6,250 | 53,250 | 0 | |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | D | 17.40 | 2,500 | 43,500 | 0 | |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | D | 74.40 | 3,051 | 226,994 | 0 | |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | D | 120.24 | 1,458 | 175,310 | 0 | |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | D | 74.64 | 1,458 | 108,825 | 0 | |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | D | 111.84 | 1,458 | 163,063 | 0 | |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | D | 31.92 | 152 | 4,852 | 0 | |
Nov 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 20,910 | 0 | 168,672 | 147.8 K to 168.7 K (+14.15 %) |
Nov 19 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.38 | 300,000 | 415,470 | 668,672 | 368.7 K to 668.7 K (+81.37 %) |
Nov 19 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.33 | 200,000 | 265,080 | 368,672 | 168.7 K to 368.7 K (+118.57 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,450 | 0 | 3,190 | 1.7 K to 3.2 K (+83.33 %) |
Jun 05 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.73 | 55,000 | 40,150 | 55,000 | |
May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 7,937 | 0 | 1,042,251 | 1 M to 1 M (+0.77 %) |
May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 7,937 | 0 | 1,042,251 | 1 M to 1 M (+0.77 %) |
May 21 2018 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.71 | 75,000 | 53,250 | 75,000 | |
May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 22.15 | 15,000 | 332,250 | 1,034,314 | 1 M to 1 M (-1.43 %) |
May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 11.66 | 15,000 | 174,900 | 1,049,314 | 1 M to 1 M (+1.45 %) |
Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 7.97 | 15,000 | 119,550 | 0 | |
Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 24.05 | 15,000 | 360,750 | 1,034,314 | 1 M to 1 M (-1.43 %) |
Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 7.97 | 15,000 | 119,550 | 1,049,314 | 1 M to 1 M (+1.45 %) |
Dec 06 2017 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Grant | A | 0.89 | 96,629 | 86,000 | 1,797,306 | 1.7 M to 1.8 M (+5.68 %) |
Sep 22 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.40 | 10,000 | 254,000 | 0 | 10 K to 0 (-100.00 %) |
Sep 20 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 27.63 | 127,790 | 3,530,838 | 1,034,314 | 1.2 M to 1 M (-11.00 %) |
Sep 20 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 27.76 | 72,210 | 2,004,550 | 1,162,104 | 1.2 M to 1.2 M (-5.85 %) |
Jul 25 2017 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 0.91 | 1,000,000 | 910,000 | 1,770,677 | 770.7 K to 1.8 M (+129.76 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,740 | 0 | 19,946 | 18.2 K to 19.9 K (+9.56 %) |
Jun 02 2017 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 1.45 | 30,000 | 43,500 | 30,000 | |
May 26 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 19.57 | 11,686 | 228,695 | 11,686 | |
May 26 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 5,843 | 0 | 1,234,314 | 1.2 M to 1.2 M (+0.48 %) |
Mar 23 2017 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.23 | 300,000 | 368,100 | 700,677 | 400.7 K to 700.7 K (+74.87 %) |
Mar 23 2017 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.20 | 200,000 | 239,800 | 400,677 | 200.7 K to 400.7 K (+99.66 %) |
Mar 21 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 10.53 | 10,000 | 105,300 | 0 | |
Mar 21 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 21.66 | 10,000 | 216,600 | 1,228,471 | 1.2 M to 1.2 M (-0.81 %) |
Mar 21 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 10.53 | 10,000 | 105,300 | 1,238,471 | 1.2 M to 1.2 M (+0.81 %) |
Jun 09 2016 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,590 | 0 | 18,170 | 16.6 K to 18.2 K (+9.59 %) |
Jun 03 2016 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 6.20 | 36,620 | 227,044 | 36,620 | |
May 26 2016 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 6.30 | 40,000 | 252,000 | 40,000 | |
Jan 05 2016 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 15,071 | 0 | 1,228,471 | 1.2 M to 1.2 M (+1.24 %) |
Nov 20 2015 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 0.52 | 5,000 | 2,600 | 5,000 | |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 2.66 | 15,677 | 41,701 | 1,823 | |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 1.74 | 17,500 | 30,450 | 0 | |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 0.38 | 17,500 | 6,650 | 0 | |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | M | 2.66 | 15,677 | 41,701 | 200,677 | 185 K to 200.7 K (+8.47 %) |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | M | 1.74 | 17,500 | 30,450 | 185,000 | 167.5 K to 185 K (+10.45 %) |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | M | 0.38 | 17,500 | 6,650 | 167,500 | 150 K to 167.5 K (+11.67 %) |
Jul 27 2015 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Buy | P | 304.98 | 5,000 | 1,524,895 | 5,000 | 0 to 5 K |
Jul 27 2015 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Buy | P | 304.78 | 5,000 | 1,523,880 | 5,000 | 0 to 5 K |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 | |
Jun 11 2015 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,040 | 0 | 16,580 | 15.5 K to 16.6 K (+6.69 %) |
May 28 2015 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 3.13 | 40,000 | 125,200 | 40,000 |
Page: 1